Zobrazeno 1 - 4
of 4
pro vyhledávání: '"William Z. Potte"'
Publikováno v:
Biomarkers in Neuropsychiatry, Vol 4, Iss , Pp 100029- (2021)
Our current diagnostic methods for treatment planning in Psychiatry and Neurodevelopmental Disabilities leave room for improvement, and null results in clinical trials in these fields may be a result of insufficient tools for patient stratification.
Externí odkaz:
https://doaj.org/article/d2abec5326834a61a3053d230d9071d7
Autor:
Judith L. Rapoport, Gail F. Ritchie, Markus J.P. Kruesi, Ivan N. Mefford, Josephine Elia, Charles S. Gulotta, F. Xavier Castellanos, William Z. Potte
Publikováno v:
Psychiatry Research. 52:305-316
Cerebrospinal fluid (CSF), plasma, and urinary monoamine metabolites were determined for 29 boys, aged 6–12, with attention-deficit hyperactivity disorder (ADHD). Levels of CSF 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), and 3-met
Publikováno v:
Frontiers in Integrative Neuroscience, Vol 13 (2019)
Biological treatment development for syndromal neuropsychiatric conditions such as autism has seen slow progress for decades. Speeding drug discovery may result from the judicious development and application of biomarker measures of brain function to
Externí odkaz:
https://doaj.org/article/8df8fd02aa844154913a8f93f8a4b20d
Autor:
Leah M. Fleming, Daniel C. Javitt, Cameron S. Carter, Joshua T. Kantrowitz, Ragy R. Girgis, Lawrence S. Kegeles, John D. Ragland, Richard J. Maddock, Tyler A. Lesh, Costin Tanase, James Robinson, William Z. Potter, Marlene Carlson, Melanie M. Wall, Tse-Hwei Choo, Jack Grinband, Jeffrey Lieberman, John H. Krystal, Philip R. Corlett
Publikováno v:
NeuroImage: Clinical, Vol 22, Iss , Pp - (2019)
Ketamine is an uncompetitive N-methyl-d-aspartate (NMDA) glutamate receptor antagonist. It induces effects in healthy individuals that mimic symptoms associated with schizophrenia. We sought to root these experiences in altered brain function, specif
Externí odkaz:
https://doaj.org/article/11febe31fb8443d1b081e08d479a69f3